Michael Fried

Title: Michael Fried - Innovator in Pharmaceutical Composition

Introduction

Michael Fried is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dyspepsia. His innovative approach has led to the development of a unique pharmaceutical composition that addresses this common digestive issue.

Latest Patents

Michael Fried holds 1 patent for his invention titled "Pharmaceutical composition and method for treatment of dyspepsia." This patent focuses on compositions that contain lipase inhibitors, such as orlistat, and their application in treating, reducing, or preventing functional dyspepsia after the ingestion of meals, especially those that are fat-rich.

Career Highlights

Fried is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization has allowed him to further his research and development efforts in creating effective treatments for digestive disorders.

Collaborations

Throughout his career, Michael Fried has collaborated with esteemed colleagues, including Christine Feinle and Thomas Rades. These partnerships have enhanced his research and contributed to the advancement of pharmaceutical innovations.

Conclusion

Michael Fried's contributions to the field of pharmaceuticals, particularly through his patent for a composition aimed at treating dyspepsia, highlight his role as an innovator. His work continues to impact the industry positively, showcasing the importance of research and collaboration in developing effective medical solutions.